— GLP-1 / GIP / GCGR Tri-Agonist
Retatrutide

Next-generation tri-agonist driving the new wave of metabolic studies.
Retatrutide is an investigational tri-agonist research peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. A leading subject of emerging metabolic literature; 10mg is the prevailing analytical spec.
Spec
10mg · Lyophilized
Mass
10.11 mg
Purity
99.5%
Triple incretin pathway co-activation; elevated metabolic modulation potential vs. dual agonists.
Reconstitute with 2 mL bacteriostatic water for a 5 mg/mL working concentration.
Store lyophilized at -20 °C. Reconstituted material stable at 2–8 °C for 28 days.
Price · Per Vial
$148.00
10mg
Research & Operations
Frequently Asked Questions
Clinical-grade answers to the questions that matter most in advanced research procurement.